|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Reed AB and Parekh DJ: Biomarkers for
prostate cancer detection. Expert Rev Anticancer Ther. 10:103–114.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bill-Axelson A, Holmberg L, Garmo H, Rider
JR, Taari K, Busch C, Nordling S, Häggman M, Andersson SO,
Spångberg A, et al: Radical prostatectomy or watchful waiting in
early prostate cancer. N Engl J Med. 370:932–942. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Coelho RF, Rocco B, Patel MB, Orvieto MA,
Chauhan S, Ficarra V, Melegari S, Palmer KJ and Patel VR:
Retropubic, laparoscopic, and robot-assisted radical prostatectomy:
A critical review of outcomes reported by high-volume centers. J
Endourol. 24:2003–2015. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ficarra V, Borghesi M, Suardi N, De Naeyer
G, Novara G, Schatteman P, De Groote R, Carpentier P and Mottrie A:
Long-term evaluation of survival, continence and potency (SCP)
outcomes after robot-assisted radical prostatectomy (RARP). BJU
Int. 112:338–345. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ficarra V, Cavalleri S, Novara G, Aragona
M and Artibani W: Evidence from robot-assisted laparoscopic radical
prostatectomy: A systematic review. Eur Urol. 51:45–56. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ficarra V, Novara G, Artibani W, Cestari
A, Galfano A, Graefen M, Guazzoni G, Guillonneau B, Menon M,
Montorsi F, et al: Retropubic, laparoscopic and robot-assisted
radical prostatectomy: A systematic review and cumulative analysis
of comparative studies. Eur Urol. 55:1037–1063. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Srivastava A, Chopra S, Pham A,
Sooriakumaran P, Durand M, Chughtai B, Gruschow S, Peyser A,
Harneja N, Leung R, et al: Effect of a risk-stratified grade of
nerve-sparing technique on early return of continence after
robot-assisted laparoscopic radical prostatectomy. Eur Urol.
63:438–444. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pound CR, Partin AW, Eisenberger MA, Chan
DW, Pearson JD and Walsh PC: Natural history of progression after
PSA elevation following radical prostatectomy. JAMA. 281:1591–1597.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gleason DF and Mellinger GT: Prediction of
prognosis for prostatic adenocarcinoma by combined histological
grading and clinical staging. J Urol. 111:58–64. 1974. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Boorjian SA, Karnes RJ, Rangel LJ,
Bergstralh EJ and Blute ML: Mayo Clinic validation of the D'amico
risk group classification for predicting survival following radical
prostatectomy. J Urol. 179:1354–1361. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bastian PJ, Boorjian SA, Bossi A, Briganti
A, Heidenreich A, Freedland SJ, Montorsi F, Roach M III, Schröder
F, van Poppel H, et al: High-risk prostate cancer: From definition
to contemporary management. Eur Urol. 61:1096–1106. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cooperberg MR, Vickers AJ, Broering JM and
Carroll PR: Comparative risk-adjusted mortality outcomes after
primary surgery, radiotherapy, or androgen-deprivation therapy for
localized prostate cancer. Cancer. 116:5226–5234. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Petrelli F, Vavassori I, Coinu A,
Borgonovo K, Sarti E and Barni S: Radical prostatectomy or
radiotherapy in high-risk prostate cancer: A systematic review and
metaanalysis. Clin Genitourin Cancer. 12:215–224. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yossepowitch O, Briganti A, Eastham JA,
Epstein J, Graefen M, Montironi R and Touijer K: Positive surgical
margins after radical prostatectomy: A systematic review and
contemporary update. Eur Urol. 65:303–313. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mossanen M, Nepple KG, Grubb RL III,
Androile GL, Kallogjeri D, Klein EA, Stephenson AJ and Kibel AS:
Heterogeneity in definitions of high-risk prostate cancer and
varying impact on mortality rates after radical prostatectomy. Eur
Urol Oncol. 1:143–148. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
D'Amico AV, Whittington R, Malkowicz SB,
Schultz D, Blank K, Broderick GA, Tomaszewski JE, Renshaw AA,
Kaplan I, Beard CJ and Wein A: Biochemical outcome after radical
prostatectomy, external beam radiation therapy, or interstitial
radiation therapy for clinically localized prostate cancer. JAMA.
280:969–974. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Amin MB, Greene FL, Edge SB, Compton CC,
Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR and
Winchester DP: The eighth edition AJCC Cancer staging manual:
Continuing to build a bridge from a population-based to a more
‘personalized’ approach to cancer staging. CA Cancer J Clin.
67:93–99. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Walsh PC: Anatomic radical prostatectomy:
Evolution of the surgical technique. J Urol. 160:2418–2424. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Castiglione F, Ralph DJ and Muneer A:
Surgical techniques for managing post-prostatectomy erectile
dysfunction. Curr Urol Rep. 18:902017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nguyen LN, Head L, Witiuk K, Punjani N,
Mallick R, Cnossen S, Fergusson DA, Cagiannos I, Lavallée LT,
Morash C and Breau RH: The risks and benefits of cavernous
neurovascular bundle sparing during radical prostatectomy: A
systematic review and meta-analysis. J Urol. 198:760–769. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Michl U, Tennstedt P, Feldmeier L, Mandel
P, Oh SJ, Ahyai S, Budäus L, Chun FKH, Haese A, Heinzer H, et al:
Nerve-sparing surgery technique, not the preservation of the
neurovascular bundles, leads to improved long-term continence rates
after radical prostatectomy. Eur Urol. 69:584–589. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
D'Amico AV, Whittington R, Malkowicz SB,
Fondurulia J, Chen MH, Kaplan I, Beard CJ, Tomaszewski JE, Renshaw
AA, Wein A and Coleman CN: Pretreatment nomogram for
prostate-specific antigen recurrence after radical prostatectomy or
external-beam radiation therapy for clinically localized prostate
cancer. J Clin Oncol. 17:168–172. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shikanov SA, Thong A, Gofrit ON, Zagaja
GP, Steinberg GD, Shalhav AL and Zorn KC: Robotic laparoscopic
radical prostatectomy for biopsy Gleason 8 to 10: Prediction of
favorable pathologic outcome with preoperative parameters. J
Endourol. 22:1477–1481. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kumar A, Samavedi S, Bates AS, Mouraviev
V, Coelho RF, Rocco B and Patel VR: Safety of selective nerve
sparing in high risk prostate cancer during robot-assisted radical
prostatectomy. J Robot Surg. 11:129–138. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yuh B, Artibani W, Heidenreich A, Kimm S,
Menon M, Novara G, Tewari A, Touijer K, Wilson T, Zorn KC and
Eggener SE: The role of robot-assisted radical prostatectomy and
pelvic lymph node dissection in the management of high-risk
prostate cancer: A systematic review. Eur Urol. 65:918–927. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yuh BE, Ruel NH, Mejia R, Wilson CM and
Wilson TG: Robotic extended pelvic lymphadenectomy for
intermediate- and high-risk prostate cancer. Eur Urol.
61:1004–1010. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fujita N, Koie T, Ohyama C, Tanaka Y, Soma
O, Matsumoto T, Yamamoto H, Imai A, Tobisawa Y, Yoneyama T, et al:
Overall survival of high-risk prostate cancer patients who received
neoadjuvant chemohormonal therapy followed by radical prostatectomy
at a single institution. Int J Clin Oncol. 22:1087–1093. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Koie T, Mitsuzuka K, Yoneyama T, Narita S,
Kawamura S, Kaiho Y, Tsuchiya N, Tochigi T, Habuchi T, Arai Y, et
al: Neoadjuvant luteinizing-hormone-releasing hormone agonist plus
low-dose estramustine phosphate improves prostate-specific
antigen-free survival in high-risk prostate cancer patients: A
propensity score-matched analysis. Int J Clin Oncol. 20:1018–1025.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Casey JT, Meeks JJ, Greco KA, Wu SD and
Nadler RB: Outcomes of locally advanced (T3 or greater) prostate
cancer in men undergoing robot-assisted laparoscopic prostatectomy.
J Endourol. 23:1519–1522. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lavery HJ, Nabizada-Pace F, Carlucci JR,
Brajtbord JS and Samadi DB: Nerve-sparing robotic prostatectomy in
preoperatively high-risk patients is safe and efficacious. Urol
Oncol. 30:26–32. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Connolly SS, Cathcart PJ, Gilmore P,
Kerger M, Crowe H, Peters JS, Murphy DG and Costello AJ: Robotic
radical prostatectomy as the initial step in multimodal therapy for
men with high-risk localised prostate cancer: Initial experience of
160 men. BJU Int. 109:752–759. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jayram G, Decastro GJ, Large MC, Razmaria
A, Zagaja GP, Shalhav AL and Brendler CB: Robotic radical
prostatectomy in patients with high-risk disease: A review of
short-term outcomes from a high-volume center. J Endourol.
25:455–457. 2011. View Article : Google Scholar : PubMed/NCBI
|
